New inhalation-optimized itraconazole nanoparticle-based dry powders for the treatment of invasive pulmonary aspergillosis
Christophe Duret,1 Nathalie Wauthoz,1 Thami Sebti,2 Francis Vanderbist,2 Karim Amighi11Laboratoire de Pharmacie Galénique et de Biopharmacie, Université Libre de Bruxelles, Brussels, Belgium; 2SMB Laboratoires, Brussels, BelgiumPurpose: Itraconazole (ITZ) dry powders fo...
Main Authors: | Duret C, Wauthoz N, Sebti T, Vanderbist F, Amighi K |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2012-10-01
|
Series: | International Journal of Nanomedicine |
Online Access: | http://www.dovepress.com/new-inhalation-optimized-itraconazole-nanoparticle-based-dry-powders-f-a11305 |
Similar Items
-
Aggregated Nanotransfersomal Dry Powder Inhalation
of Itraconazole for Pulmonary Drug Delivery
by: Mehdi Hassanpour Aghdam, et al.
Published: (2016-03-01) -
A Critical Review on Emerging Trends in Dry Powder Inhaler Formulation for the Treatment of Pulmonary Aspergillosis
by: Shen Nam Cheng, et al.
Published: (2020-11-01) -
Role of itraconazole in the management of aspergillosis in treated patients of pulmonary tuberculosis
by: Gupta P, et al.
Published: (2005-01-01) -
Itraconazole in chronic pulmonary aspergillosis: In whom, for how long, and at what dose?
by: Venkata Nagarjuna Maturu, et al.
Published: (2015-01-01) -
Pulmonary aspergillosis treated with inhaled amphotericin B
by: Qian-Yi Zhou, et al.
Published: (2017-01-01)